Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Brighton and Sussex University Hospitals NHS Trust | OTHER |
| Instituut voor Tropische Geneeskunde, Belgium | OTHER |
| Klinika za infektivne bolesti (KIB), Zagreb, Croatia | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
A large (3900 patients) cohort study, undertaken in five European sites to validate in a mHealth platform to enable self-management of HIV in patients with stable disease using a tailored HTA process, Model for Assessment of Telemedicine Applications (MAST), specifically developed for the assessment of mHealth solutions.
As site recruitment will be sequential and the recruitment period will last 18 months, a maximum follow-up of 35 Months will be undertaken. Study visits will take place at baseline defined as the time of mHealth introduction, months 6, 12, 18, 24 and 30.
Number of Study Centres: 5 Duration of Study: 35 Months Criteria for Evaluation: Usability of the mHealth platform, patient self-management and empowerment, clinical safety (virological suppression maintenance, CD4 count, laboratory parameters, adverse events and adherence), quality of life and self-economy will be assessed by questionnaires and laboratory parameters.
Routine data on patient demographics, treatment and investigations which will include viral load, CD4, haematology, biochemistry and urine sample. Patient Activation Measure, Quality of life, adherence questionnaire and economic questionnaires will be performed at baseline and at months 12 and 24. Satisfaction System Usability Scale will be evaluated at month 12 and 24.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| mHealth platform | Experimental | Stable HIV-1 infected subjects will be followed-up using an mHealth platform. The platform will provide users with web based and mobile device applications which interface securely with relevant medical data and facilitate remote access to healthcare providers. The minimum length of follow-up will be 12 months and the maximum 35 months. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| mHealth platform | Other | Use of a mHealth platform to inform and empower patient of hies/her own health |
|
| Measure | Description | Time Frame |
|---|---|---|
| Changes in Patient Activation Measure (PAM-13) questionnaire from baseline | months 12 and 24 |
| Measure | Description | Time Frame |
|---|---|---|
| Changes in Satisfaction System Usability Scale (SUS) | months 12 and 24 | |
| Maintenance of virological suppression (HIV-1 RNA <50 c/ml) | months 12 and 24 | |
| Change in CD4 count |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Jennifer Whetham, MD | Contact | +44 1273 523081 | Jennifer.Whetham@bsuh.nhs.uk | |
| Agathe León, MD | Contact | +34932275400 | 2447 | aleon@clinic.ub.es |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Prins Leopold Instituut Voor Tropische Geneeskunde | Recruiting | Antwerp | 2000 | Belgium |
Not provided
| Centro Hospitalar de Lisboa Central |
| OTHER |
| Fundacion Clinic per a la Recerca Biomédica | OTHER |
| University of Brighton | OTHER |
| Podmedics, ( POD), Northwood, United Kingdom | UNKNOWN |
| Universidad Politecnica de Madrid | OTHER |
| National Prospective Monitoring System HIV Health-economics Collaboration, (NPMS), Richmond, United Kingdom | UNKNOWN |
| European Aids Treatment Group (EATG), Brussels, Belgium | UNKNOWN |
| mHealth Futures LTD, Brighton, United Kingdom | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
| months 12 and 24 |
| Change in blood lipid profile | months 12 and 24 |
| Changes in Quality of life (EQ-5D-5L questionnaire) from baseline | months 12 and 24 |
| Changes in Quality of life (PROQOL-HIV questionnaire) from baseline | months 12 and 24 |
| Changes in adherence quantified by Morisky-Green questionnaire | months 12 and 24 |
| Percentage of patients with changes in ART from baseline | months 12 and 24 |
| Changes on self-reported economic questionnaire aspects from baseline | months 12 and 24 |
| Klinika za Infektivne Bolesti Dr. Fran Mihaljevic | Recruiting | Zagreb | 10000 | Croatia |
|
| Centro Hospitalar de Lisboa Central | Recruiting | Lisbon | 1169 097 | Portugal |
|
| Hospital Clínic i Provincial | Recruiting | Barcelona | 08036 | Spain |
|
| University of Brighton | Recruiting | Brighton | BN2 4AT | United Kingdom |
|
| ID | Term |
|---|---|
| D015658 | HIV Infections |
| ID | Term |
|---|---|
| D000086982 | Blood-Borne Infections |
| D003141 | Communicable Diseases |
| D007239 | Infections |
| D015229 | Sexually Transmitted Diseases, Viral |
| D012749 | Sexually Transmitted Diseases |
| D016180 | Lentivirus Infections |
| D012192 | Retroviridae Infections |
| D012327 | RNA Virus Infections |
| D014777 | Virus Diseases |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D007153 | Immunologic Deficiency Syndromes |
| D007154 | Immune System Diseases |
Not provided
Not provided